Lichen Planopilaris in Children: A Systematic Review

Małgorzata Papierzewska1, Anna Waśkiel-Burnat1, Lidia Rudnicka1

  • 1Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.

Pediatric Dermatology
|December 4, 2024
PubMed

Insights

Pediatric lichen planopilaris (LPP) presents with scarring and inflammation, often diagnosed via trichoscopy and biopsy. Treatments including corticosteroids and other agents show effectiveness in children with this rare scarring alopecia.

Area of Science:

  • Dermatology
  • Pediatric Dermatology
  • Trichology

Background:

  • Lichen planopilaris (LPP) is a primary scarring alopecia, most common in adults but also affecting children.
  • Understanding pediatric LPP is crucial for early diagnosis and management of hair loss in young individuals.

Purpose of the Study:

  • To systematically review the clinical, trichoscopic, and histopathologic features of pediatric lichen planopilaris.
  • To discuss therapeutic management strategies for LPP in children and adolescents.

Main Methods:

  • Systematic review conducted following PRISMA guidelines.
  • Searched PubMed, Scopus, and EBSCO databases, with the last search on June 18, 2024.
  • Analyzed 12 studies encompassing 20 pediatric cases.

Main Results:

  • Male predominance noted in pediatric LPP.
  • Common clinical signs include scarring, perifollicular erythema, scaling, plugging, atrophy, and hyperkeratotic papules, primarily on the vertex.
  • Key trichoscopic findings: scaling, blue-gray dots, perifollicular erythema, absent follicular ostia. Histopathology shows perifollicular fibrosis, lymphocytic inflammation, pigment incontinence, and dermal scarring.
  • Positive treatment responses observed with corticosteroids, methotrexate, pioglitazone, and tocilizumab.

Conclusions:

  • Lichen planopilaris is an uncommon cause of scarring alopecia in the pediatric population.
  • Consider LPP in the differential diagnosis of patchy hair loss in children.
Abstract

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
99